BioSpace News Archive

Evogene Ltd., a leading biotechnology company developing novel products for life science markets, announced that Ofer Haviv, Evogene’s President and CEO, will present at the Jefferies 2019 Industrials Conference taking place in New York City, August 6-8, 2019.

Original metastatic castration-resistant prostate cancer and immunotherapy-refractory non-small cell lung cancer cohorts expanded to 80 subjects

Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, which is marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today announced the appointment of four members to its Medical Advisory Board.

DicernaTM Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of ribonucleic acid interference (RNAi) therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted a Breakthrough Therapy Designation (BTD) to DCR-PHXC for the treatment of patients with primary hyperoxaluria type 1 (PH1).

Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center (“MD Anderson”), today announced additional positive data from its proof of concept clinical trial for the reduction of cellulite.

The Hyundai Hope On Wheels non-profit embarks on a nationwide tour this Summer to award new grants for pediatric cancer, surpassing $160 million in lifetime funding for research [15-July-2019] ROCHESTER, N.Y. , July 15, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501c3 non-profit organization supported by Hyundai and its U.S. dealers, announces $100,000 H

Recursion, a next-gen biopharma company combining automated, experimental biology with artificial intelligence to discover and develop drugs at scale, today announced the closing of a $121 million Series C financing.

Hexion Inc. (“Hexion” or the “Company”) is serving as the Start Line sponsor of 2019 American Heart Association (“AHA”) Central Ohio Heart Walk on August 24 in downtown Columbus.

Omnicell, Inc. (NASDAQ: OMCL) today issued the following statement in response to a report issued on July 11, 2019 by self-proclaimed short-seller GlassHouse Research

Columbia Care Inc. (“Columbia Care” or the “Company”) (NEO: CCHW, OTCQX: COLXF), one of the largest fully-integrated operators in the global medical cannabis industry with licenses across the US and the EU, is pleased to announce that its US dollar denominated shares will begin trading in the United States on the OTCQX® Best Market (“QTCQX”) under the symbol “COLXF” effective today.